Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (221-230 of 303) with videos related to

Pageof 31
Sort By:
Cancers|April 16, 2020
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal CancerHan Gyul Yoon, Dongryul Oh, Yong Chan Ahn, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 24, 2024
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinomaTae Hee Hong, Tae Ho Kim, Genehee Lee, et al.
Cancer Research and Treatment|October 30, 2015
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell CarcinomaHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|January 6, 2017
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute ExperienceHyojung Park, Dongryul Oh, Yong Chan Ahn, et al.
Annals of Surgical Oncology|February 14, 2014
Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapyHyebin Lee, Yong Chan Ahn, Hongryull Pyo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumorsSilvia Park, Myung-ju Ahn, Jin Seok Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2016
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?Hakyoung Kim, Yong Chan Ahn, Hongryull Pyo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2012
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgeryHee Kyung Ahn, Yoon-La Choi, Joung Ho Han, et al.
Journal of Korean Neurosurgical Society|December 3, 2020
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife RadiosurgeryMin Ho Lee, Kyung-Rae Cho, Jung Won Choi, et al.
Pageof 31

Showing results (221-230 of 303) with videos related to

Sort By:
Pageof 31
Cancers|April 16, 2020
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal CancerHan Gyul Yoon, Dongryul Oh, Yong Chan Ahn, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 24, 2024
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinomaTae Hee Hong, Tae Ho Kim, Genehee Lee, et al.
Cancer Research and Treatment|October 30, 2015
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell CarcinomaHae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Research and Treatment|January 6, 2017
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute ExperienceHyojung Park, Dongryul Oh, Yong Chan Ahn, et al.
Annals of Surgical Oncology|February 14, 2014
Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapyHyebin Lee, Yong Chan Ahn, Hongryull Pyo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumorsSilvia Park, Myung-ju Ahn, Jin Seok Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2016
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?Hakyoung Kim, Yong Chan Ahn, Hongryull Pyo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2012
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgeryHee Kyung Ahn, Yoon-La Choi, Joung Ho Han, et al.
Journal of Korean Neurosurgical Society|December 3, 2020
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife RadiosurgeryMin Ho Lee, Kyung-Rae Cho, Jung Won Choi, et al.
Pageof 31